Cite
HARVARD Citation
Hashimoto, K. et al. (2022). Prognostic Potential of Metabolic Activity on 18F-FDG Accumulation in Advanced NSCLC Receiving Combining Chemotherapy Plus PD-1 Blockade. Journal of immunotherapy. 45 (8), pp. 349-357. [Online].